Standout Papers
- Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non–Small-Cell Lung Cancer Previously Treated With Chemotherapy (2004)
- Tumor Marker Utility Grading System: a Framework to Evaluate Clinical Utility of Tumor Markers (1996)
- Hospital and Physician Volume or Specialization and Outcomes in Cancer Treatment: Importance in Quality of Cancer Care (2000)
Immediate Impact
6 by Nobel laureates 4 from Science/Nature 82 standout
Citing Papers
Selpercatinib in Patients With RET Fusion–Positive Non–Small-Cell Lung Cancer: Updated Safety and Efficacy From the Registrational LIBRETTO-001 Phase I/II Trial
2022 Standout
The mucin-selective protease StcE enables molecular and functional analysis of human cancer-associated mucins
2019 StandoutNobel
Works of Christopher E. Desch being referenced
Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non–Small-Cell Lung Cancer Previously Treated With Chemotherapy
2004 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Christopher E. Desch | 3815 | 739 | 2879 | 892 | 64 | 6.0k | |
| Philip C. Prorok | 3037 | 299 | 3094 | 788 | 131 | 6.4k | |
| Jean-Yves Douillard | 3023 | 367 | 3029 | 834 | 70 | 5.5k | |
| Boštjan Šeruga | 4311 | 461 | 1795 | 1594 | 123 | 7.2k | |
| Laura F. Hutchins | 3952 | 497 | 1673 | 1448 | 120 | 7.1k | |
| Yu‐Ning Wong | 2035 | 658 | 1613 | 1385 | 129 | 4.9k | |
| Rosemary Yancik | 3705 | 613 | 1344 | 867 | 39 | 6.6k | |
| M.L.G. Janssen‐Heijnen | 3972 | 453 | 1989 | 837 | 127 | 6.7k | |
| Christina Lacchetti | 3695 | 314 | 1334 | 624 | 62 | 6.5k | |
| Lazzaro Repetto | 2915 | 708 | 1376 | 446 | 100 | 6.1k | |
| Veena Shankaran | 3396 | 1550 | 1531 | 604 | 111 | 5.7k |
All Works
Loading papers...